World's Best Scientists 2026 revealed!

D-Index & Metrics

Social Sciences and Humanities

D-Index
65
Citations
16088
World Ranking
1035
National Ranking
198

Linda Davies publication distribution in Social Sciences and Humanities in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Social Sciences and Humanities in 2026. The highlighted bar marks where Linda Davies sits on this spectrum.

44–53 publications: 28 scientists 54–63 publications: 61 scientists 64–73 publications: 161 scientists 74–83 publications: 225 scientists 84–93 publications: 301 scientists 94–103 publications: 390 scientists 104–113 publications: 406 scientists 114–123 publications: 474 scientists 124–133 publications: 453 scientists 134–143 publications: 434 scientists 144–153 publications: 407 scientists 154–163 publications: 411 scientists 164–173 publications: 391 scientists 174–183 publications: 313 scientists 184–193 publications: 319 scientists 194–203 publications: 304 scientists 204–213 publications: 285 scientists 214–223 publications: 246 scientists 224–233 publications: 213 scientists 234–243 publications: 170 scientists 244–253 publications: 167 scientists 254–263 publications: 162 scientists 264–273 publications: 138 scientists 274–283 publications: 138 scientists 284–293 publications: 113 scientists 294–303 publications: 106 scientists 304–313 publications: 95 scientists 314–323 publications: 101 scientists 324–333 publications: 81 scientists 334–343 publications: 69 scientists 344–353 publications: 56 scientists 354–363 publications: 36 scientists 364–373 publications: 42 scientists 374–383 publications: 41 scientists 384–393 publications: 44 scientists 394–403 publications: 27 scientists 404–413 publications: 30 scientists 414–423 publications: 20 scientists 424–433 publications: 29 scientists 434–443 publications: 29 scientists 444–453 publications: 25 scientists 454–463 publications: 19 scientists 464–473 publications: 21 scientists 474–483 publications: 11 scientists 484–493 publications: 17 scientists 494–503 publications: 7 scientists 504–513 publications: 6 scientists 514–523 publications: 12 scientists 524–533 publications: 10 scientists 534–543 publications: 7 scientists 544–553 publications: 6 scientists 554–563 publications: 12 scientists 564–569 publications: 8 scientists 570+ publications: 100 scientists
44 publications 570+

This scientist: 317 publications — 89th percentile

89% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 570 publications or more.

Linda Davies D-index placement in Social Sciences and Humanities in 2026

The chart shows the D-index (discipline H-index) distribution of Social Sciences and Humanities scientists ranked by Research.com in 2026. The highlighted bar marks where Linda Davies sits on this spectrum.

30 D-Index: 177 scientists 31 D-Index: 210 scientists 32 D-Index: 222 scientists 33 D-Index: 188 scientists 34 D-Index: 181 scientists 35 D-Index: 243 scientists 36 D-Index: 261 scientists 37 D-Index: 272 scientists 38 D-Index: 278 scientists 39 D-Index: 300 scientists 40 D-Index: 297 scientists 41 D-Index: 308 scientists 42 D-Index: 313 scientists 43 D-Index: 300 scientists 44 D-Index: 269 scientists 45 D-Index: 260 scientists 46 D-Index: 228 scientists 47 D-Index: 251 scientists 48 D-Index: 203 scientists 49 D-Index: 186 scientists 50 D-Index: 187 scientists 51 D-Index: 166 scientists 52 D-Index: 138 scientists 53 D-Index: 141 scientists 54 D-Index: 131 scientists 55 D-Index: 137 scientists 56 D-Index: 109 scientists 57 D-Index: 129 scientists 58 D-Index: 95 scientists 59 D-Index: 105 scientists 60 D-Index: 106 scientists 61 D-Index: 86 scientists 62 D-Index: 94 scientists 63 D-Index: 77 scientists 64 D-Index: 79 scientists 65 D-Index: 59 scientists 66 D-Index: 68 scientists 67 D-Index: 51 scientists 68 D-Index: 49 scientists 69 D-Index: 40 scientists 70 D-Index: 43 scientists 71 D-Index: 40 scientists 72 D-Index: 50 scientists 73 D-Index: 46 scientists 74 D-Index: 43 scientists 75 D-Index: 45 scientists 76 D-Index: 45 scientists 77 D-Index: 30 scientists 78 D-Index: 25 scientists 79 D-Index: 31 scientists 80 D-Index: 29 scientists 81 D-Index: 18 scientists 82 D-Index: 21 scientists 83 D-Index: 26 scientists 84 D-Index: 15 scientists 85 D-Index: 15 scientists 86 D-Index: 19 scientists 87 D-Index: 19 scientists 88 D-Index: 12 scientists 89 D-Index: 7 scientists 90 D-Index: 19 scientists 91 D-Index: 20 scientists 92 D-Index: 13 scientists 93 D-Index: 9 scientists 94 D-Index: 13 scientists 95 D-Index: 8 scientists 96 D-Index: 7 scientists 97 D-Index: 6 scientists 98 D-Index: 6 scientists 99 D-Index: 6 scientists 100+ D-Index: 97 scientists
30 D-Index 100+

This scientist: 65 D-Index — 87th percentile

87% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 100 D-Index or more.

Overview

Linda Davies is affiliated with the University of Manchester in the United Kingdom. Their research spans the fields of Medicine and Psychology, focusing particularly on General Health Professions, Clinical Psychology, Psychiatry and Mental Health, Economics and Econometrics, and Cardiology and Cardiovascular Medicine.

Their work covers several main topics including:

  • Schizophrenia research and treatment
  • Health Systems, Economic Evaluations, Quality of Life
  • Cardiac Health and Mental Health
  • Autism Spectrum Disorder Research
  • Stroke Rehabilitation and Recovery
  • Geriatric Care and Nursing Homes
  • Family and Disability Support Research

Linda Davies has contributed publications to various frequent venues such as:

  • Programme Grants for Applied Research
  • BMJ Open
  • Health Technology Assessment
  • Value in Health
  • The Lancet Oncology

Among recent papers, they have been involved in the following publications:

  • Second-line FOLFOX chemotherapy versus active symptom control for advanced biliary tract cancer (ABC-06): a phase 3, open-label, randomised, controlled trial, 2021, The Lancet Oncology
  • What is important to people with dementia living at home? A set of core outcome items for use in the evaluation of non-pharmacological community-based health and social care interventions, 2020, Age and Ageing
  • Improving the Effectiveness of Psychological Interventions for Depression and Anxiety in Cardiac Rehabilitation: PATHWAY-A Single-Blind, Parallel, Randomized, Controlled Trial of Group Metacognitive Therapy, 2021, Circulation
  • Antipsychotic medication versus psychological intervention versus a combination of both in adolescents with first-episode psychosis (MAPS): a multicentre, three-arm, randomised controlled pilot and feasibility study, 2020, The Lancet Psychiatry
  • Factors Limiting Subgroup Analysis in Cost-Effectiveness Analysis and a Call for Transparency, 2021, PharmacoEconomics

Frequent co-authors who have collaborated extensively with Linda Davies include:

  • Gemma Shields
  • David Reeves
  • Adrian Wells
  • Lora Capobianco
  • Patrick Doherty

Best Publications

  • Randomized Controlled Trial of the Effect on Quality of Life of Second- vs First-Generation Antipsychotic Drugs in Schizophrenia: Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1)

    Peter B. Jones;Thomas R. E. Barnes;Linda Davies;Graham Dunn

  • Second-line FOLFOX chemotherapy versus active symptom control for advanced biliary tract cancer (ABC-06): a phase 3, open-label, randomised, controlled trial.

    Angela Lamarca;Daniel H Palmer;Harpreet Singh Wasan;Paul J Ross

  • Randomised controlled trial of cognitive-behavioural therapy in early schizophrenia: acute-phase outcomes.

    Shôn Lewis;Nicholas Tarrier;Gillian Haddock;Richard Bentall

  • Randomized Controlled Trial of Effect of Prescription of Clozapine Versus Other Second-Generation Antipsychotic Drugs in Resistant Schizophrenia

    Shôn W. Lewis;Thomas R. E. Barnes;Linda Davies;Robin M. Murray

  • Economic Analysis Alongside Clinical Trials: Revisiting the Methodological Issues

    Michael F. Drummond;Linda Davies

  • Generalisability in economic evaluation studies in healthcare: a review and case studies.

    Sculpher Mj;Pang Fs;Manca A;Drummond Mf

  • Early detection and intervention evaluation for people at risk of psychosis: multisite randomised controlled trial

    Anthonty P. Morrison;Paul French;Suzanne L.K. Stewart;Max Birchwood

  • Current practice, accuracy, effectiveness and cost-effectiveness of the school entry hearing screen.

    J Bamford;H Fortnum;K Bristow;J Smith

  • Patient empowerment: The need to consider it as a measurable patient-reported outcome for chronic conditions

    Marion McAllister;Graham Dunn;Katherine Payne;Linda Davies

  • Cognitive therapy for people with schizophrenia spectrum disorders not taking antipsychotic drugs: a single-blind randomised controlled trial

    Anthony P Morrison;Anthony P Morrison;Douglas Turkington;Douglas Turkington;Melissa Pyle;Melissa Pyle;Helen Spencer;Helen Spencer

  • Cognitive-behavioural therapy in first-episode and early schizophrenia: 18-month follow-up of a randomised controlled trial

    Nicholas Tarrier;Shôn Lewis;Gillian Haddock;Richard Bentall

  • Randomised controlled trials of conventional antipsychotic versus new atypical drugs, and new atypical drugs versus clozapine, in people with schizophrenia responding poorly to, or intolerant of, current drug treatment.

    Sarah Lewis;L Davies;Pamela Jones;T R E Barnes

  • Cost-effectiveness of cardiac rehabilitation: a systematic review

    Gemma E Shields;Adrian Wells;Patrick Doherty;Anthony Heagerty

  • Integrated motivational interviewing and cognitive behavioural therapy for people with psychosis and comorbid substance misuse: randomised controlled trial

    Christine Barrowclough;Gillian Haddock;Til Wykes;Ruth Beardmore

  • Economics and schizophrenia: the real cost.

    Linda M. Davies;Michael F. Drummond

  • ABC-06 | A randomised phase III, multi-centre, open-label study of active symptom control (ASC) alone or ASC with oxaliplatin / 5-FU chemotherapy (ASC+mFOLFOX) for patients (pts) with locally advanced / metastatic biliary tract cancers (ABC) previously-treated with cisplatin/gemcitabine (CisGem) chemotherapy.

    Angela Lamarca;Daniel H. Palmer;Harpreet Singh Wasan;Paul J. Ross

  • Cognitive-behavioural therapy and motivational intervention for schizophrenia and substance misuse. 18-month outcomes of a randomised controlled trial.

    Gillian Haddock;Christine Barrowclough;Nicholas Tarrier;Jan Moring

  • The economic burden of schizophrenia

    Linda M. Davies;Michael F. Drummond

  • Effectiveness of enhanced communication therapy in the first four months after stroke for aphasia and dysarthria: a randomised controlled trial

    Audrey Bowen;Anne Hesketh;Emma Patchick;Alys Young

  • Cost-effectiveness of cell salvage and alternative methods of minimising perioperative allogeneic blood transfusion: a systematic review and economic model.

    L Davies;TJ Brown;S Haynes;K Payne

Frequent Co-Authors

Graham Dunn
Graham Dunn University of Manchester
Shôn Lewis
Shôn Lewis University of Manchester
Michael Drummond
Michael Drummond University of York
Charles McCollum
Charles McCollum University of Manchester
Thomas R. E. Barnes
Thomas R. E. Barnes Imperial College London
Anthony P. Morrison
Anthony P. Morrison University of Manchester
David Challis
David Challis University of Nottingham
Nicholas Tarrier
Nicholas Tarrier University of Manchester
Seena Fazel
Seena Fazel University of Oxford
Peter Jones
Peter Jones University of Cambridge

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you are considering studying Social Sciences and Humanities in the USA, there are flexible online degree pathways to help elevate your career. Many students pursue an online masters degree psychology to build foundational knowledge for roles in counseling, research, and education. Online programs allow for study alongside work or family commitments.

Those aiming for advanced clinical roles often consider accredited psyd programs. These programs train future psychologists with a focus on hands-on practice and licensure preparation. Another promising track is in marriage and family therapy. Students seeking accelerated options can benefit from marriage and family therapy online programs that help professionals enter this growing field faster.

If your interests align with leadership and education, an online doctorate of education programs can help you achieve top qualifications for academic, administrative, or policy roles. Each of these paths has unique admission requirements, career outcomes, and time commitments—do your research to find the best fit for your goals.

Best Scientists Citing Linda Davies

Trending Scientists

Recently Published Articles